A recent analysis of hospital-based cross-sectional studies indicates that nearly half of patients with type 2 diabetes (T2D) are deficient in essential micronutrients, particularly vitamin D. The research, published in BMJ Nutrition, Prevention & Health, reviewed data from 132 studies, encompassing 52,501 participants from 1998 to 2023.
Read More
The findings reveal a pooled prevalence of micronutrient deficiency at 45.3%, with women with T2D experiencing higher rates (48.62%) compared to men (42.53%). Vitamin D deficiency was found to be the most widespread, affecting 60.45% of the cohort, followed by magnesium deficiency at 41.95%, and vitamin B12 deficiency at 23.78%, which was even higher (28.72%) among those treated with metformin.
Geographical variations in deficiency rates were observed, suggesting that dietary habits and environmental factors may influence nutrient status among T2D patients. The researchers noted that factors such as genetics, sedentary lifestyles, and obesity might increase the risk for T2D, implicating that micronutrients play a critical role in glucose metabolism and insulin signaling.
The authors suggest that deficiencies in substances like biotin, chromium, thiamine, vitamin D, and vitamin C could have significant metabolic implications. This highlights the interaction between nutrient deficiencies and chronic diseases, emphasizing that T2D is linked not only to glucose metabolism but also to broader nutritional imbalances.
Health experts indicate that current diabetes management often prioritizes macronutrient intake and glycemic control, which may overlook the crucial need to address micronutrient levels. Shane McAuliffe from the NNEdPro Global Institute for Food, Nutrition and Health pointed out that this reveals a simultaneous problem of nutritional deficiencies alongside diet-related diseases such as T2D, advocating for a more holistic approach to treatment.
The study, however, has limitations, primarily as most of the data originated from hospital-based studies, making it challenging to ascertain whether the deficiencies are a cause or a result of poor glycemic control. A noted discrepancy showed a higher prevalence of deficiencies in hospital settings (46%) as opposed to community settings (22%), though the analysis included far fewer community studies. Despite these limitations, the review's 25-year scope and extensive database coverage without language or geographic constraints strengthen its findings.
The authors concluded that these insights can help tackle the rising issue of micronutrient deficiencies among T2D patients and their potential long-term medical implications.